NCT06942234 2025-09-17Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast CancerJiangsu Alphamab Biopharmaceuticals Co., LtdPhase 1/2 Recruiting180 enrolled